Projects per year
Personal profile
Education
- 2018 PhD, Graduate Institute of Clinical Medicine, College of Medicine, National Yang-Ming University
- 2003 MD, College of Medicine, National Defense Medical Center
Experience
- Director, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Director, Division of Gynecology, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Attending, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- 2023.02- Associate Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- Assistant Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- 2012.05-2019.03 Attending, Department of Obstetrics & Gynecology,Taipei Veterans General Hospital
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Kuo-Chang Wen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
透過子宮頸拭子之 DNA 甲基化生物標記來評估與偵測卵巢腫瘤的風險(3/3)
Wen, K.-C. (PI)
8/1/26 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Detection &. Risk Assessment of Ovarian Tumors by Dna Methylation Biomarkers from Cervical Swab
Wen, K.-C. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Detection &. Risk Assessment of Ovarian Tumors by Dna Methylation Biomarkers from Cervical Swab
Wen, K.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of New Dna Methylation Biomarkers to Improve the Performance of Self-Sampling Mpap (Mpap 2.0)
Wen, K.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of New Dna Methylation Biomarkers to Improve the Performance of Self-Sampling Mpap (Mpap 2.0) (1/2)
Wen, K.-C. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or Worse
Chen, C. C., Hsiao, K. Y., Lu, S. C., Bai, C. H., Wen, K. C. & Wang, Y. H., 2026, In: Journal of Lower Genital Tract Disease. 30, 2, p. 100-109 10 p.Research output: Contribution to journal › Article › peer-review
-
Programmed death-ligand 1 upregulation is associated with poor prognosis in patients with epithelial ovarian cancer
Liu, C. H., Chao, W. T., Yang, S. T., Lin, C. H., Wen, K. C. & Wang, P. H., 2026, In: Journal of the Chinese Medical Association. 89, 1, p. 25-34 10 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Link opens in a new tab Citations (Scopus) -
A DNA methylation assay (MPap) using self-collected tampon versus cytology collection swab for endometrial cancer detection
Su, K. M., Wen, K. C., Lin, Y. H., Su, P. H., Chen, L. Y. & Lai, H. C., 2025, In: International Journal of Gynecology and Obstetrics. 173, 3, p. 1400-1407 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Combined pembrolizumab and bevacizumab therapy in heavily treated recurrent ovarian cancer
Wang, S.-Y., Chou, Y. T., Wen, K.-C., Liew, P.-L., Lu, Y.-H., Chen, L.-Y., Sung, P. L., Lai, H.-C. & Chu, L.-H., Aug 2025, In: European Journal of Gynaecological Oncology. 46, 8, p. 48Research output: Contribution to journal › Article › peer-review
-
Exploring potential methylation markers for ovarian cancer from cervical scraping samples
Lien, J. Y., Hii, L. A., Su, P. H., Chen, L. Y., Wen, K. C., Lai, H. C. & Wang, Y. C., Dec 2025, In: Human Genomics. 19, 1, 56.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (Scopus)
Datasets
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor) & Wen, K.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
Dataset
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
Dataset